BVT Knock-Out PGR/ DE000VD15278 /
| 2024-05-13 7:46:10 PM | Chg.+0.140 | Bid9:59:54 PM | Ask9:59:54 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 3.320EUR | +4.40% | - Bid Size: - |
- Ask Size: - |
Progressive Corporat... | 249.18 USD | 2078-12-31 | Put |
GlobeNewswire
4:01 PM
Pythian’s Vanessa Simmons and Donna Williston Honored by CRN on 2024 Women of the Channel Lists
GlobeNewswire
3:33 PM
Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Se...
GlobeNewswire
3:33 PM
Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial...
GlobeNewswire
2:35 PM
DeFi Technologies Inc. Featured in Syndicated Broadcast Covering Subsidiary’s AUM of C$748M, a 47.2%...
GlobeNewswire
2:15 PM
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update
GlobeNewswire
2:00 PM
GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
2:00 PM
Avalyn Announces Multiple Presentations on its Lead Program, AP01, for Pulmonary Fibrosis and its Ap...
GlobeNewswire
1:30 PM
BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transt...
GlobeNewswire
1:00 PM
Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab
GlobeNewswire
1:00 PM
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 20...
GlobeNewswire
12:00 PM
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...
GlobeNewswire
8:30 AM
Inventiva announces the publication in Nature Communications of additional results from NATIVE Phase...
GlobeNewswire
05-09
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st ...
GlobeNewswire
05-09
Freeline Presents Positive New Data from Phase 1/2 Trial of FLT201, Its Novel Gene Therapy Candidate...
GlobeNewswire
05-08
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Plan...
GlobeNewswire
05-07
MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-1...
GlobeNewswire
05-06
Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...
GlobeNewswire
05-04
The National Fire Sprinkler Association's Class of 2024: Honoring Fire Sprinkler Industry Greats
GlobeNewswire
05-02
PyroGenesis Announces 28-Day Lab Strength Tests Achieve Up to 99.56% Above Compressive Strength Targ...
GlobeNewswire
05-01
Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...
GlobeNewswire
05-01
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 ...
